This product is an unconjugated anti-Human Complement C3c Monoclonal antibody (CTJS-135) generated from the Rat. The antibody can be used for IP.
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
| Clonality | Monoclonal |
| Clone | CTJS-135 |
| Host Animal | Rat |
| Isotype | IgG2a |
| Immunogen | The monoclonal antibody 4 recognizes a conformational epitope in C3c, C3b and iC3b. |
| Species Reactivity | Human |
| Applications | IP |
| Application Notes | IP: 1:10-1:500 The optimal working dilutions should be determined by the end user. |
| Specificity | This antibody reacts with Human complement C3c. |
| Purity | ≥95% as determined by SDS-PAGE |
| Format | Liquid |
| Size | 25 µg |
| Storage | Store at 4°C. Do not freeze. |
| Type | Primary Antibody |
| Target Name | C3c |
| Alternative Names | Complement C3c; C3c fragment |
| Gene ID | 718 |
| UniProt ID | P01024 |
| Introduction | Complement C3c is a cleaved product of complement C3. During the activation of complement system, C3 is cleaved into C3a and C3b fragments by C3 convertase. The C3b fragment can be degraded into iC3b when cleaved by complement factor I. iC3b serves as 'inactive' C3b unable to associate with complement factor B, which prevents amplification of the complement cascade through the alternative pathway. iC3b will be cleaved by trypsin-like enzymes releasing C3c and C3dg, and C3dg can be further cleaved into C3g and C3d. |